Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINE1 | P05121 | 2/20 | 0.43 |
| ▸ | MAPK8 | P45983 | 10/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 3/20 | 0.39 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.39 |
| ▸ | EDNRB | P24530 | 1/20 | 0.39 |
| ▸ | EDNRA | P25101 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2806158 | 0.91 | KMT2A (0.45) | SERPINE1MAPK8MEN1USP2ALDH1A1 | |
| SCHEMBL2805537 | 0.89 | SERPINE1 (0.46) | SERPINE1MAPK8MEN1USP2ALDH1A1 | |
| SCHEMBL2810307 | 0.88 | SERPINE1 (0.41) | SERPINE1MAPK8MEN1USP2ALDH1A1 | |
| SCHEMBL2805766 | 0.88 | SERPINE1 (0.45) | SERPINE1MAPK8MEN1USP2ALDH1A1 | |
| SCHEMBL4397413 | 0.88 | SERPINE1 (0.52) | SERPINE1MAPK8MEN1USP2ALDH1A1 | |
| SCHEMBL13168627 | 0.87 | KMT2A (0.40) | SERPINE1MAPK8MEN1USP2ALDH1A1 | |
| SCHEMBL2806169 | 0.87 | SERPINE1 (0.42) | SERPINE1MAPK8MEN1USP2ALDH1A1 | |
| SCHEMBL2805777 | 0.84 | SERPINE1 (0.42) | SERPINE1MEN1ALDH1A1KMT2APPARG | |
| SCHEMBL2807928 | 0.82 | KDM4E (0.44) | SERPINE1MEN1USP2ALDH1A1KMT2A | |
| SCHEMBL2806962 | 0.81 | CYP19A1 (0.46) | SERPINE1MAPK8PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100240642-A1 | 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators | SMITHKLINE BEECHAM CORPORATION (US) | 2010-09-23 | — | — | US | disclosed |
| US-20100240642-A1 | 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators | SMITHKLINE BEECHAM CORPORATION (US) | 2010-09-23 | — | — | US | disclosed |
| CN-101563322-A | 1H-indole-2-carboxylic acid derivatives useful as PPAR modulators | SMITHKLINE BEECHAM CORPORAITON (US) | 2009-10-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240642-A1 | 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators | PPARD, PPARA, PPARG | SERPINE1 4215/4885MAPK8 2290/4885MEN1 4809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.